5min chapter

Business Of Biotech cover image

Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski

Business Of Biotech

CHAPTER

Advancements in Epigenetic Reprogramming

This chapter highlights the recent breakthroughs at Life Biosciences, particularly focusing on their clinical trials in partial epigenetic reprogramming for optic neuropathies. It also discusses their accolades, including recognition as a top biotech in Boston and participation in significant medical conferences, showcasing their innovative contributions to the field.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode